Exane Derivatives’s Tapestry TPR Stock Holding History

Exane Derivatives’s Portfolio TPR Stock Details TPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,550	Closed	-$116K	–	556
2014 Q4	$116K	Buy	+1,550	New	+$54.7K	0.02%	268

Other funds holding TPR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's TPR Position: Q2 2022 in Review

Exane Derivatives sold out of Tapestry (TPR) in Q2 2022, closing a stake of 8 shares — an estimated $297 sold.

Exane Derivatives first reported a position in TPR in Q4 2015 and held it in 22 quarters. The position peaked at $4.4M in Q1 2017. 557 funds tracked by Wall St. Rank hold TPR as of Q2 2022.

Exane Derivatives reported no remaining Tapestry position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 8 Tapestry shares in Q2 2022, an estimated $297.
Exane Derivatives first reported a position in Tapestry in Q4 2015 and held it in 22 quarters.
Exane Derivatives's Tapestry position peaked at $4.4M in Q1 2017.
557 funds tracked by Wall St. Rank held Tapestry as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.